| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/03/1995 | EP0650485A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| 05/03/1995 | EP0650483A1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS |
| 05/03/1995 | EP0650367A1 Blocking intercellular interactions with cd43 chimeric molecules |
| 05/03/1995 | EP0650360A1 Phosphono derivatives as antiinflammatory and antiarthritic agents |
| 05/03/1995 | EP0502997B1 Use of gamma-interferon for the manufacture of a medicament in the treatment of steroid dependent asthma |
| 05/03/1995 | EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives |
| 05/02/1995 | US5412145 P2'-modified hydroxamic acid collagenase inhibitors |
| 05/02/1995 | US5412141 Bisphosphonic acid derivatives as anti-arthritic agents |
| 05/02/1995 | US5412073 Polypeptides and DNA coding therefor |
| 05/02/1995 | US5411993 Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol |
| 05/02/1995 | US5411882 Cytokine which mediates inflammation |
| 05/02/1995 | US5411743 Prevention of synovial adhesions |
| 05/02/1995 | CA1335452C Substituted tetralins, chromans and related compounds in the treatment of asthma |
| 05/02/1995 | CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| 05/02/1995 | CA1335450C Indole and indazole keto sulphones as leukotriene antagonists |
| 04/29/1995 | CA2134418A1 Linear adhesion inhibitors |
| 04/27/1995 | WO1995011259A1 Platelet-derived growth factor analogues |
| 04/27/1995 | WO1995011254A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 04/27/1995 | WO1995011235A1 Pyrimidinones as antiarthritic and anti-inflammatories |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995002406A3 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 04/27/1995 | WO1994027594A3 Stable copper(i) complexes and methods related thereto |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2134317A1 L-selectin cleavage site, methods of diagnosis and usage thereof |
| 04/27/1995 | CA2134179A1 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 04/26/1995 | EP0649657A1 Pharmaceutical combinations containing a NSAID and an opioid analgesic |
| 04/26/1995 | EP0649468A1 Soluble cr1 derivatives |
| 04/26/1995 | EP0649432A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 04/26/1995 | EP0649418A1 7-(2-aminoethyl)-benzothiazolones |
| 04/26/1995 | EP0649409A1 Vinyl arenas having retinoid-like activity |
| 04/26/1995 | EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs. |
| 04/26/1995 | EP0524180B1 Taste masking of ibuprofen by fluid bed coating |
| 04/25/1995 | USRE34918 Antihistamines, muscle relaxants |
| 04/25/1995 | US5410061 Pharmaceutical compounds |
| 04/25/1995 | US5409899 Pseudopeptide compounds having anti-inflammatory activity |
| 04/25/1995 | US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof |
| 04/25/1995 | US5409701 From flexibacter culture; human leukocyte elastase inhibitor |
| 04/20/1995 | WO1995010531A1 Oligopeptides derived from c-reactive protein fragments |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 04/20/1995 | WO1995010286A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/20/1995 | WO1995010284A1 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 04/20/1995 | WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/1995 | CA2173456A1 Inhibitors of phosphoinositide-specific phospholipase c |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648223A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 04/19/1995 | EP0648209A1 Contrast agents for mr diagnosis |
| 04/19/1995 | EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors |
| 04/19/1995 | EP0648125A1 Anti-inflammatory agent |
| 04/19/1995 | EP0550635B1 Fused ring analogs of nitrogen containing nonaromatic heterocycles |
| 04/19/1995 | EP0451299B1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
| 04/19/1995 | CN1101644A Thiadiazinones |
| 04/19/1995 | CN1028227C Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same |
| 04/18/1995 | US5407923 Antiinflammatory agents |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009841A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 04/13/1995 | WO1995009831A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009627A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995009624A1 Compounds, compositions and treatment of allergies and inflammation |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | DE4341139C1 Dimethicone for the treatment of aphthae |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/12/1995 | EP0647616A1 Zinc tranexamate compound |
| 04/12/1995 | EP0647451A1 Inclusion complex of beta-cyclodextrin with diclofenac |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647226A1 9-AMINOPYRIDAZINO 4',5' : 3,4]pyrrolo 2,1-a]ISOQUINOLINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. |
| 04/12/1995 | EP0647220A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 04/12/1995 | EP0647137A1 Glycine receptor antagonists and the use thereof |
| 04/12/1995 | EP0647136A1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative. |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/11/1995 | US5405852 Amide derivatives |
| 04/11/1995 | US5405840 Pranoprofen-containing, suspending medicinal composition |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995008985A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | CA2172601A1 Perfluorocarbons as anti-inflammatory agents |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/05/1995 | EP0646593A1 Corticoid-17,21-dicarboxylic acid ester and corticosteroid-17-carboxylic acid ester-21-carbonic, process for their production and medicaments containing them |
| 04/05/1995 | EP0646578A1 Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them |
| 04/05/1995 | EP0646569A1 Novel carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |